MQS Management’s ResMed RMD Stock Holding History

MQS Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$211K	Sell	942 -497	-35%	-$124K	0.14%	326
2025 Q4	$347K	Buy	+1,439	New	+$368K	0.2%	211
2023 Q3	–	Sell	-2,232	Closed	-$488K	–	593
2023 Q2	$488K	Sell	2,232 -585	-21%	-$130K	0.33%	96
2023 Q1	$617K	Buy	2,817 +797	+39%	+$173K	0.4%	54
2022 Q4	$420K	Buy	+2,020	New	+$444K	0.29%	131
2022 Q1	–	Sell	-1,116	Closed	-$291K	–	410
2021 Q4	$291K	Buy	+1,116	New	+$290K	0.47%	95

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MQS Management's RMD Position: Q1 2026 in Review

MQS Management reduced its ResMed (RMD) stake by 35% in Q1 2026, selling an estimated $124K and leaving 942 shares worth $211K. The position accounts for 0.14% of the portfolio, ranked #326.

MQS Management first reported a position in RMD in Q4 2021 and has held it in 6 quarters since. The position peaked at $617K in Q1 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

MQS Management held 942 shares of ResMed worth $211K as of Q1 2026.
MQS Management sold 497 ResMed shares in Q1 2026, an estimated $124K.
ResMed made up 0.14% of MQS Management's portfolio in Q1 2026, its #326 holding.
MQS Management first reported a position in ResMed in Q4 2021 and has held it in 6 quarters since.
MQS Management's ResMed position peaked at $617K in Q1 2023.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.